Lavipharm is a dynamic, international healthcare company listed on the Athens Stock Exchange since 1995, based in Greece. Their manufacturing plant is one of the few pharmaceutical manufacturing sites in Europe with fully integrated production lines, including dedicated lines for transdermal drug delivery systems (TDDS). The production facility covers 8,000 m2 and produces tablets, capsules, transdermal systems, oral liquids, creams, and ointments under strict GMP conditions. Lavipharm collaborates with FAMAR for contract manufacturing and has launched the first locally produced medical cannabis prescription product in Greece. They also partner with other companies for manufacturing services.
Transdermal drug delivery systems (TDDS), pharmaceutical manufacturing, tablets, capsules, oral liquids, topicals, medical cannabis
1 site worldwide
No certifications on file yet.
No reviews available yet.
No documents available.